Denali Therapeutics Inc. buy BiotechBee
Start price
08.09.24
/
70%
€23.00
Target price
30.05.27
€31.00
Performance (%)
-4.35%
End price
14.12.24
€22.00
Summary
This prediction ended on 14.12.24 with a price of €22.00. With a performance of -4.35%, the BUY prediction for Denali Therapeutics Inc. by BiotechBee closed slightly in the red. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Denali Therapeutics Inc. | -9.510% | -9.510% | -30.046% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
According to BiotechBee what are the pros and cons of Denali Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year